The scientist’s investigation covers issues in Internal medicine, Endocrinology, Surgery, Risk factor and Osteoporosis. Internal medicine is closely attributed to Placebo in his research. The study incorporates disciplines such as Cortical bone, Calcium metabolism and Parathyroid hormone in addition to Endocrinology.
In his study, Forearm is strongly linked to Cohort study, which falls under the umbrella field of Surgery. The Risk factor study combines topics in areas such as Odds ratio, Relative risk, Blood pressure, Atrial fibrillation and Type 2 diabetes. His Osteoporosis research is multidisciplinary, incorporating perspectives in Hormone replacement therapy, Age related and Vertebral body.
Leif Mosekilde mainly focuses on Internal medicine, Endocrinology, Osteoporosis, Surgery and Vitamin D and neurology. His work on Placebo expands to the thematically related Internal medicine. His work carried out in the field of Endocrinology brings together such families of science as Calcium metabolism, Parathyroid hormone and Osteocalcin.
His Osteoporosis research is multidisciplinary, relying on both Physical therapy, Menopause and Raloxifene. His studies in Surgery integrate themes in fields like Relative risk, Case-control study, Cohort study and Risk factor. His Vitamin D and neurology study combines topics from a wide range of disciplines, such as Vitamin and Secondary hyperparathyroidism.
His primary areas of investigation include Internal medicine, Endocrinology, Vitamin D and neurology, Hypoparathyroidism and Placebo. His study in Internal medicine is interdisciplinary in nature, drawing from both Gastroenterology and Surgery. The various areas that Leif Mosekilde examines in his Endocrinology study include Calcium metabolism, Parathyroid hormone and Familial hypocalciuric hypercalcemia.
His Vitamin D and neurology research incorporates themes from Vitamin, Myocardial infarction and Animal science. Leif Mosekilde has researched Hypoparathyroidism in several fields, including Postural stability and Epidemiology. His studies examine the connections between Placebo and genetics, as well as such issues in Leptin, with regards to Osteocalcin and Weight loss.
Leif Mosekilde focuses on Internal medicine, Endocrinology, Hypoparathyroidism, Placebo and Vitamin D and neurology. His Methylmalonic acid study in the realm of Internal medicine interacts with subjects such as Trustworthiness. His Hypoparathyroidism study combines topics in areas such as Quality of life, Parathyroid hormone and Pediatrics.
Leif Mosekilde focuses mostly in the field of Placebo, narrowing it down to matters related to Randomized controlled trial and, in some cases, Relative risk, Angina, Meta-analysis and Physical therapy. His biological study spans a wide range of topics, including Myocardial infarction, Acute coronary syndrome, Vitamin and Cohort study. The Bone remodeling study which covers Osteoporosis that intersects with Orthopedic surgery.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial.
Louise Lind Schierbeck;Lars Rejnmark;Charlotte Landbo Tofteng;Lis Stilgren.
BMJ (2012)
Effects of thyroid hormones on bone and mineral metabolism.
Leif Mosekilde;Erik Fink Eriksen;Peder Charles.
Endocrinology and Metabolism Clinics of North America (1990)
Vitamin D and the elderly
Leif Mosekilde.
Clinical Endocrinology (2005)
Serum markers of type I collagen formation and degradation in metabolic bone disease: Correlation with bone histomorphometry
Erik F. Eriksen;Peder Charles;Flemming Melsen;Leif Mosekilde.
Journal of Bone and Mineral Research (2009)
Hypoparathyroidism in the adult: Epidemiology, diagnosis, pathophysiology, target‐organ involvement, treatment, and challenges for future research
John P Bilezikian;Aliya Khan;John T Potts;Maria Luisa Brandi.
Journal of Bone and Mineral Research (2011)
Fracture Risk in Patients with Celiac Disease, Crohn’s Disease, and Ulcerative Colitis: A Nationwide Follow-up Study of 16,416 Patients in Denmark
Peter Vestergaard;Leif Mosekilde.
American Journal of Epidemiology (2002)
Vitamin D and calcium supplementation prevents osteoporotic fractures in elderly community dwelling residents: a pragmatic population-based 3-year intervention study.
Erik Roj Larsen;Leif Mosekilde;Anders Foldspang.
Journal of Bone and Mineral Research (2003)
Cancellous bone remodeling occurs in specialized compartments lined by cells expressing osteoblastic markers
Ellen M. Hauge;Dorte Qvesel;Erik Fink Eriksen;Leif Mosekilde.
Journal of Bone and Mineral Research (2001)
Sex differences in age-related changes in vertebral body size, density and biomechanical competence in normal individuals.
Lis Mosekilde;Leif Mosekilde.
Bone (1990)
Cohort study of risk of fracture before and after surgery for primary hyperparathyroidism.
Peter Vestergaard;Charlotte L Mollerup;Vibe Gedsø Frøkjær;Peer Christiansen.
BMJ (2000)
Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking h-index is inferred from publications deemed to belong to the considered discipline.
If you think any of the details on this page are incorrect, let us know.
Steno Diabetes Center
Aarhus University Hospital
University of Southern Denmark
University of Oslo
Finnish Institute for Health and Welfare
University of Western Australia
University of Helsinki
University of Manchester
University of Maryland, Baltimore
deCODE Genetics (Iceland)
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: